In vivo detection of phospholipase C by enzyme-activated near-infrared probes.
In vivo detection of phospholipase C by enzyme-activated near-infrared probes.
复制标题
DOI：
10.1021/bc200242v
复制
发表时间：
2011-12-21
影响因子：
4.7
通讯作者：
Delikatny, E. James
中科院分区：
文献类型：
--
作者：
Mawn, Theresa M.;Popov, Anatoliy V.;Beardsley, Nancy J.;Stefflova, Klara;Milkevitch, Matthew;Zheng, Gang;Delikatny, E. James
In this paper the characterization of the first near-infrared (NIR) phospholipase-activated molecular beacon is reported and its utility for in vivo cancer imaging is demonstrated. The probe consists of three elements: a phospholipid (PL) backbone to which the NIR fluorophore, pyropheophorbide a (Pyro), and the NIR Black Hole Quencher 3 (BHQ) were conjugated. Due to the close proximity of BHQ to Pyro, the Pyro-PtdEtn-BHQ probe is self-quenched until enzyme hydrolysis releases the fluorophore. The Pyro-PtdEtn-BHQ probe is highly specific to one isoform of phospholipase C, phosphatidylcholine-specific phospholipase C (PC-PLC), responsible for catabolizing phosphatidylcholine directly to phosphocholine. Incubation of Pyro-PtdEtn-BHQ in vitro with PC-PLC demonstrated a 150-fold increase in fluorescence that could be inhibited by the specific PC-PLC inhibitor tricyclodecan-9-yl xanthogenate (D609) with an IC50 of 34±8 µM. Since elevations in phosphocholine have been consistently observed by magnetic resonance spectroscopy in a wide array of cancer cells and solid tumors, we assessed the utility of Pyro-PtdEtn-BHQ as a probe for targeted tumor imaging. Injection of Pyro-PtdEtn-BHQ into mice bearing DU145 human prostate tumor xenografts followed by in vivo NIR imaging resulted in a 4-fold increase in tumor radiance over background and a 2 fold increase in the tumor:muscle ratio. Tumor fluorescence enhancement was inhibited with administration of D609. The ability to image PC-PLC activity in vivo provides a unique and sensitive method of monitoring one of the critical phospholipase signaling pathways activated in cancer, as well as the phospholipase activities that are altered in response to cancer treatment.
登录
查看更多内容
影响因子：
7.4
作者：
Ansari, Mubeen Ahmad;Joshi, Gururaj;Butterfield, D. Allan
通讯作者：
Butterfield, D. Allan
影响因子：
4.8
作者：
Bogdanov, AA;Lin, CP;Weissleder, R
通讯作者：
Weissleder, R
影响因子：
6.4
作者：
Eliyahu, Galit;Kreizman, Tamar;Degani, Hadassa
通讯作者：
Degani, Hadassa
影响因子：
4.8
作者：
Farber, SA;Olson, ES;Halpern, ME
通讯作者：
Halpern, ME
影响因子：
11.2
作者：
Al-Saffar, NMS;Troy, H;Chung, YL
通讯作者：
Chung, YL